Skip to main content
HR 5939 116th Congress House

Triple-Negative Breast Cancer Research and Education Act of 2019

Official title: To provide for research and education with respect to triple-negative breast cancer, and for other purposes.

Introduced: February 21, 2020 See on congress.gov
Health CancerGovernment information and archivesHealth information and medical recordsHealth programs administration and funding
More subjectsShow fewer subjects
Health promotion and preventive careMedical educationMedical researchMinority healthResearch administration and fundingWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 21, 2020
Referred to the House Committee on Energy and Commerce.
Feb 21, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 21, 2020

Referred to the House Committee on Energy and Commerce.

 Plain-English summary Congressional Research Service

Triple-Negative Breast Cancer Research and Education Act of 2019

This bill requires research and education activities related to triple-negative breast cancer. (The cells of these breast cancers are negative for estrogen receptors, progesterone receptors, and excess HER2 protein.)

The National Institutes of Health must conduct and support research into the disease, and the Centers for Disease Control and Prevention and the Health Resources and Services Administration must develop and disseminate information about triple-negative breast cancer for the public and for health care providers, respectively. Among other topics, the information must cover the elevated risk for minority women and the availability of a range of treatment options for such cancers.

 Related & companion bills 2
  • HR 113 Reintroduced Bill Triple-Negative Breast Cancer Research and Education Act of 2021
  • HR 1984 Reintroduction of Triple-Negative Breast Cancer Research and Education Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5939: Triple-Negative Breast Cancer Research and Education Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5939/
MLA
"H.R. 5939: Triple-Negative Breast Cancer Research and Education Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5939/.
Bluebook (legal)
H.R. 5939, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5939/.
Markdown link
[H.R. 5939: Triple-Negative Breast Cancer Research and Education Act of 2019](https://openamerica.io/bill/116-HR-5939/)
Report a problem